Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Siderov

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 8, 2009
Reducing workplace cytotoxic surface contamination using a closed-system drug transfer deviceJim Siderov, Sue Kirsa, Robert McLauchlan
Asia-Pacific Journal of Clinical Oncology|March 11, 2023
Clinical Oncology Society of Australia Position Statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settingsMarissa Ryan, Neil Lam, Kate Wright, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership surveyAlexandre Chan, Himanshu Patel, Jim Siderov, et al.
Asia-Pacific Journal of Clinical Oncology|June 13, 2022
Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer?Robert Nicolae, Anthony Uccellini, Jim Siderov, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy PractitionersEmma Foreman, Himanshu Patel, Jim Siderov, et al.
Frontiers in Oncology|November 28, 2022
Therapeutic drug monitoring in oncology - What's out there: A bibliometric evaluation on the topicJana Stojanova, Jane E Carland, Bridin Murnion, et al.
Leukemia & Lymphoma|October 25, 2022
Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass indexTamasine Stewart, Mark Dowling, Brett Janson, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2020
A consensus statement on the use of biosimilar medicines in hematology in AustraliaGareth P Gregory, Christine Carrington, Chan Y Cheah, et al.
Asia-Pacific Journal of Clinical Oncology|October 5, 2010
The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapyChristine Carrington, Leanne Stone, Bogda Koczwara, et al.
Australian Journal of General Practice|August 4, 2025
Pre- and post-treatment care for actinic keratoses: An Australian and New Zealand perspectiveJohn O'Bryen, Solange Green, A J Seine, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 8, 2009
Reducing workplace cytotoxic surface contamination using a closed-system drug transfer deviceJim Siderov, Sue Kirsa, Robert McLauchlan
Asia-Pacific Journal of Clinical Oncology|March 11, 2023
Clinical Oncology Society of Australia Position Statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settingsMarissa Ryan, Neil Lam, Kate Wright, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership surveyAlexandre Chan, Himanshu Patel, Jim Siderov, et al.
Asia-Pacific Journal of Clinical Oncology|June 13, 2022
Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer?Robert Nicolae, Anthony Uccellini, Jim Siderov, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy PractitionersEmma Foreman, Himanshu Patel, Jim Siderov, et al.
Frontiers in Oncology|November 28, 2022
Therapeutic drug monitoring in oncology - What's out there: A bibliometric evaluation on the topicJana Stojanova, Jane E Carland, Bridin Murnion, et al.
Leukemia & Lymphoma|October 25, 2022
Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass indexTamasine Stewart, Mark Dowling, Brett Janson, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2020
A consensus statement on the use of biosimilar medicines in hematology in AustraliaGareth P Gregory, Christine Carrington, Chan Y Cheah, et al.
Asia-Pacific Journal of Clinical Oncology|October 5, 2010
The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapyChristine Carrington, Leanne Stone, Bogda Koczwara, et al.
Australian Journal of General Practice|August 4, 2025
Pre- and post-treatment care for actinic keratoses: An Australian and New Zealand perspectiveJohn O'Bryen, Solange Green, A J Seine, et al.
Pageof 3